AngioDynamics, Inc. - Common Stock — Bilan trimestriel (NASDAQ:ANGO) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?

Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?

Reasons to Add AngioDynamics Stock to Your Portfolio for Now

Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet

AngioDynamics dépose une plainte pour violation de brevet contre Endovascular Engineering

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade

AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AngioDynamics (ANGO) Upgraded to Buy: Here's Why

Freedom Broker initie la couverture d’AngioDynamics avec une recommandation d’achat

Canaccord abaisse l’objectif de cours d’AngioDynamics sur fond de pressions sur les marges

AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO)

Canaccord abaisse l’objectif de cours d’AngioDynamics sur les prévisions d’EBITDA